Global Vascular Stents Market Outlook
The global vascular stents market size was valued at USD 10.57 billion in 2023, driven by an increase in the prevalence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to achieve a value of USD 17.10 billion by 2032.
Vascular Stents: Introduction
Vascular stents are medical devices used to treat narrowed or blocked blood vessels, typically resulting from conditions such as atherosclerosis. These small, mesh-like tubes are inserted into the affected artery or vein to provide structural support, keep the vessel open, and ensure adequate blood flow to tissues and organs. Vascular stents can be made from various materials, including metal alloys and biodegradable polymers, and are often coated with medications (drug-eluting stents) to prevent restenosis, the re-narrowing of the vessel. The use of vascular stents is a common and effective procedure in interventional cardiology and vascular surgery, significantly improving patient outcomes in the treatment of coronary artery disease, peripheral artery disease, and other vascular disorders.
Get a Free Sample Report with Table of Contents –https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample
Key Trends in the Global Vascular Stents Market
Some key trends in the market include:
- Technological Advancements: Continuous innovation in stent technology, including the development of drug-eluting stents (DES), bioresorbable stents, and covered stents, is driving market growth. These advancements improve the efficacy, safety, and long-term outcomes of stent procedures, reducing complications such as restenosis and thrombosis.
- Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases (CVDs) such as coronary artery disease and peripheral artery disease is a major driver of the vascular stents market. Aging populations, sedentary lifestyles, and rising rates of obesity and diabetes contribute to the growing need for vascular interventions.
- Minimally Invasive Procedures: The shift towards minimally invasive surgical techniques is boosting the demand for vascular stents. These procedures, such as percutaneous coronary intervention (PCI), offer benefits including shorter hospital stays, faster recovery times, and reduced procedural risks, making them preferable to traditional open surgeries.
- Emerging Markets: The vascular stents market is expanding rapidly in emerging economies, driven by increasing healthcare investments, improving healthcare infrastructure, and growing awareness of advanced medical treatments. Countries in Asia Pacific, Latin America, and the Middle East are witnessing significant market growth.
- Aging Population: The global aging population is leading to a higher prevalence of vascular diseases, which in turn is increasing the demand for vascular stents. Elderly patients are more susceptible to atherosclerosis and other vascular conditions that require stent placement.
- Regulatory Approvals and Reimbursement Policies: Streamlined regulatory approval processes and favourable reimbursement policies are facilitating the adoption of new stent technologies. Supportive regulatory environments and insurance coverage make these advanced treatments more accessible to patients.
- Focus on Clinical Trials and Research: Increased focus on clinical trials and research is driving innovations in vascular stents. Ongoing studies aim to enhance the performance, durability, and safety of stents, leading to the introduction of next-generation products that better meet patient needs.
Global Vascular Stents Market Segmentation
Market Breakup by Type
- Drug-Eluting Stents
- Bare-Metal Stents
- Bio absorbable Stents
Market Breakup by Product Type
- Coronary Stents
- Peripheral Vascular Stents
- Evar Stent Grafts
- Others
Market Breakup by Material
- Metallic Stents
- Cobalt Chromium
- Platinum Chromium
- Nickel Chromium
- Stainless Steel
- Others
Market Breakup by Mode of Delivery
- Balloon – Expandable Stents
- Self – Expanding Stents
Market Breakup by End User
- Hospital and Cardiac Centres
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Vascular Stents Market Overview
The vascular stents market in North America is experiencing robust growth, driven by factors such as the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant healthcare expenditure. The region benefits from a high adoption rate of innovative medical technologies and a strong focus on research and development. Additionally, favorable reimbursement policies and supportive regulatory frameworks facilitate the rapid introduction and uptake of new stent technologies. With a growing aging population and increasing awareness of minimally invasive procedures, North America is expected to maintain its leading position in the vascular stents market during the forecast period.
Europe represents a significant market for vascular stents, characterized by a well-established healthcare system and a strong emphasis on advanced medical treatments. The region’s market growth is driven by the rising incidence of cardiovascular diseases, government initiatives to improve healthcare outcomes, and increasing investments in healthcare infrastructure.
The Asia Pacific region is poised to experience the highest growth rate in the global vascular stents market. Factors such as the rapidly expanding healthcare infrastructure, increasing healthcare spending, and a large, aging population contribute to this growth. The prevalence of cardiovascular diseases is rising in countries like China and India, creating a substantial demand for vascular stents. Additionally, the region’s growing middle class and improving access to advanced medical treatments are driving market expansion.
Latin America is emerging as a promising market for vascular stents, supported by economic improvements, increasing healthcare investments, and rising awareness of advanced medical treatments. The region’s growing burden of cardiovascular diseases and the need for effective treatment solutions are driving the demand for vascular stents. Countries such as Brazil and Mexico are witnessing significant healthcare infrastructure development and modernization, making advanced medical technologies more accessible.
The Middle East and Africa are also witnessing growth in the vascular stents market, driven by improving healthcare infrastructure, economic development, and a growing focus on advanced medical technologies. Governments in the region are investing in healthcare modernization and promoting cardiovascular health awareness. The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures are fueling market growth.
Global Vascular Stents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, founded in 1888. The company operates in various segments, including medical devices, diagnostics, nutrition, and pharmaceuticals. Abbott is a leader in the vascular stents market, particularly known for its innovative Xience family of drug-eluting stents, which are used to treat coronary artery disease. Abbott’s commitment to research and development drives the continuous improvement and introduction of advanced stent technologies, enhancing patient outcomes and maintaining its strong market position.
- Boston Scientific Corporation
Boston Scientific Corporation, founded in 1979 and headquartered in Marlborough, Massachusetts, is a leading manufacturer of medical devices used in a range of interventional medical specialties. In the vascular stents market, Boston Scientific is renowned for its advanced drug-eluting stents such as the Promus Elite™ and Synergy™ stent systems. The company focuses on innovation and clinical excellence, aiming to provide superior treatment options for patients with coronary and peripheral artery diseases. Boston Scientific’s extensive product portfolio and robust pipeline of new technologies position it as a key player in the global vascular stents market.
- Biotronik, Inc.
Biotronik, Inc., headquartered in Berlin, Germany, and founded in 1963, specializes in cardiovascular and endovascular medical technologies. The company is known for its high-quality, innovative vascular stents, including the Orsiro™ drug-eluting stent, which features a unique bioabsorbable polymer coating. Biotronik’s commitment to advancing patient care through continuous innovation and rigorous clinical research has established it as a trusted name in the vascular stents market. The company’s focus on delivering effective and reliable medical solutions supports its growth and influence in the global market.
- MicroPort Scientific Corporation
MicroPort Scientific Corporation, founded in 1998 and based in Shanghai, China, is a global medical device company that develops and manufactures a wide range of medical products, including cardiovascular devices, orthopedic implants, and neurovascular devices. In the vascular stents market, MicroPort is known for its Firehawk™ drug-eluting stent, which integrates advanced technology to enhance efficacy and safety. The company’s dedication to innovation, quality, and expanding its product portfolio has made it a significant player in the global market, particularly in emerging economies where healthcare infrastructure is rapidly developing.
- Braun Melsungen AG
- Braun Melsungen AG, established in 1839 and headquartered in Melsungen, Germany, is a leading global healthcare company specializing in medical and pharmaceutical products and services. The company offers a wide range of vascular stents through its Vascular Systems division, known for high-quality and reliable products such as the SeQuent® Please drug-coated balloon and the Coroflex® ISAR drug-eluting stent. B. Braun’s commitment to innovation, patient safety, and improving healthcare outcomes drives its development of advanced medical solutions. With a strong focus on research and development and a global presence, B. Braun continues to be a key contributor to the vascular stents market.
Other key players in the market include Meril Life Sciences Pvt. Ltd., Medtronic, BD, Biosensors International Group, Ltd., Lepu Medical Technology, Koninklijke Philips N.V., Teleflex Incorporated., and Terumo Corporation.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Mark, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
